ROYALTY PHARMA PLC CLASS A (RPRX)

Sector: Health Care

Named Executive Officers

Compensation data for top executives (showing up to 3 years of data)

ExecutiveYearSalaryBonusStock AwardsOption AwardsNon-Equity Incentive CompOther CompensationTotal Compensation
Marshall Urist, M.D., Ph.D.
Executive Vice President, Research & Investments
2025$1,323,000$0$0$0$0$0$1,323,000
2024$1,260,000$0$0$0$0$0$1,260,000
2023$1,200,000$3,360,000$0$0$0$0$4,560,000
ExecutiveYearSalaryBonusStock AwardsOption AwardsNon-Equity Incentive CompOther CompensationTotal Compensation
Terrance Coyne
Executive Vice President & Chief Financial Officer
2025$1,323,000$0$0$0$0$0$1,323,000
2024$1,260,000$0$0$0$0$0$1,260,000
2023$1,200,000$3,360,000$0$0$0$0$4,560,000
ExecutiveYearSalaryBonusStock AwardsOption AwardsNon-Equity Incentive CompOther CompensationTotal Compensation
George Lloyd
Senior Advisor; former Executive Vice President, Chief Legal Officer & Investments
2025$1,323,000$0$0$0$0$0$1,323,000
2024$1,260,000$0$0$0$0$0$1,260,000
2023$1,200,000$3,360,000$0$0$0$0$4,560,000
ExecutiveYearSalaryBonusStock AwardsOption AwardsNon-Equity Incentive CompOther CompensationTotal Compensation
Christopher Hite
Executive Vice President & Vice Chairman
2025$1,323,000$0$0$0$0$0$1,323,000
2024$1,260,000$0$0$0$0$0$1,260,000
2023$1,200,000$3,360,000$0$0$0$0$4,560,000
ExecutiveYearSalaryBonusStock AwardsOption AwardsNon-Equity Incentive CompOther CompensationTotal Compensation
Pablo Legorreta
Chief Executive Officer
2025$937,500$0$0$0$0$0$937,500
2023$1,200,000$3,360,000$0$0$0$0$4,560,000